Demographic and clinical features of the population
| Patients enrolled (N=19) | |
|---|---|
| Age, years (mean±SD) | 65±8 |
| M/F, n | 11/8 |
| IPF, n | 12 |
| Other ILDs, n | 7 |
| NSIP | 2 |
| RA-ILD | 1 |
| Chronic-HP | 1 |
| CTD-ILD | 1 |
| Asbestosis | 1 |
| DIPNECH | 1 |
| Lung function tests at baseline | |
| Per cent of predicted FVC (mean±SD) | 82±26 |
| Per cent of predicted SB-DLCO (mean±SD) | 51±19 |
| 6MWD at baseline, metres (mean±SD) | 499±87 |
| Dropouts, n (%) | 2 (10.5%) |
| Average number of sessions attended (of 9) | 8 |
6MWD, 6-min walking test distance; CTD-ILD, connective tissue disease associated interstitial lung disease; DIPNECH, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; FVC, forced vital capacity; HP, hypersensitivity pneumonitis; ILDs, interstitial lung diseases; IPF, idiopathic pulmonary fibrosis; NSIP, non-specific interstitial pneumonia; RA-ILD, rheumatoid arthritis associated interstitial lung disease; SB-DLCO, single breath diffusion lung capacity for CO.